Purchase Order HHSN273201700183P
Award Date 9/7/17
Potential Completion Date 9/6/18
Potential Value $103K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Greenville, NC 27858, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Myriad RBM, Inc., a subsidiary of Myriad Genetics Inc. The contract has a ceiling value of $64,875.00 and a completion date of September 30, 2014. The contract is for "OTHER FUNCTIONS - CSF ASSAYS TESTING" services and does not have a set-aside designation, indicating open competition. The parent company, Myriad Genetics Inc., is a...
- Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., was awarded a delivery order valued at $30,000 by the National Cancer Institute on June 25, 2007, with a completion date of September 20, 2007. This firm fixed-price contract, which carries no set-aside designation, involves the delivery of chemical-biological study services to be performed at the awardee's facility in Emigration Canyon, Utah. The National Cancer Institute, part of the National Institutes of Health, funds...
- This is a $14,207,063.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Myriad Genetics Inc., a molecular diagnostics company based in Salt Lake City, Utah. The contract is for the identification of therapeutic targets using proteomics technology. No set-aside was used, indicating open competition. The contract has a period of performance ending on September 15,...
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The $10,157.40 contract is for the provision of Myriad's Prolaris quantitative PCR testing services to assess prostate cancer tumor aggressiveness and guide treatment approaches. No set-aside designation was mentioned. Myriad Genetics, a...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Myriad RBM, Inc. for $7,200.00. The order is for bio marking services, which likely involves providing genetic testing and analysis services to assess the biological markers or genomic characteristics of patient samples. Myriad RBM, Inc. is a subsidiary of the parent company Myriad Genetics Inc., a molecular diagnostics...
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $44,280 purchase order to Myriad RBM, Inc., a subsidiary of Myriad Genetics Inc., to provide biomarker testing on patients. The contract has a period of performance from February 8, 2017 to March 17, 2017 and utilizes a firm fixed price payment structure. To be performed in Bethesda, Maryland, this contract supports NIH's efforts to advance child health...
- This is a firm fixed-price purchase order contract awarded by the Indian Health Service (IHS), a civilian agency of the U.S. government, to Myriad Genetic Laboratories Inc. The contract is for 24-GIMC laboratory services with a period of performance from May 1, 2024 to April 30, 2025. The contract has a ceiling value of $60,344. Myriad Genetic Laboratories Inc. is a for-profit organization and subsidiary of Myriad Genetics Inc. that provides personalized medicine and genetic testing services....
- This contract was awarded by the Department of Defense's Medical Command (MEDCOM) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract, valued at $75,124.60, is a Blanket Purchase Agreement (BPA) call for various genetic testing services, with an ultimate completion date of September 30, 2016. The contract is not designated as a set-aside. Myriad Genetic Laboratories, a for-profit organization specializing in personalized medicine and genetic testing services,...
- This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...